The significance of carbohydrates on G-CSF: Differential sensitivity of G-CSFs to human neutrophil elastase degradation

Journal of Leukocyte Biology

Volumn 75, Issue 3, 2004, Pages 515-522

  Carter, Clive R D ^a   Whitmore, Katie M ^a   Thorpe, Robin ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Bioassay; Deglycosylation; Glycosylation; Granulopaiesis; Proteases

Indexed keywords

CARBOHYDRATE; CD34 ANTIGEN; CYTOKINE; ELASTASE; GLYCOPROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR;

ANIMAL CELL; ARTICLE; CELL MATURATION; CELL PROLIFERATION; CHO CELL; ENZYME ACTIVITY; ENZYME DEGRADATION; ESCHERICHIA COLI; GLYCOSYLATION; GRANULOPOIESIS; NEGATIVE FEEDBACK; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN STABILITY;

AMINO ACID SUBSTITUTION; BIODEGRADATION, ENVIRONMENTAL; CARBOHYDRATE METABOLISM; DRUG STABILITY; GLYCOSYLATION; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; KINETICS; LEUKOCYTE ELASTASE; MUTATION;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; ESCHERICHIA COLI;

EID: 1542313909     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0803378     Document Type: Article

References (42)

1. Souza, L. M., Boone, T. C., Gabrilove, J., Lai, P. H., Zsebo, K. M., Murdock, D. C., Chazin, V. R., Bruszewski, J., Lu, H., Chen, K. K., Barendt, J., Platzer, E., Moore, M. S., Mertelsmann, R., Welte, K. (1986) Recombinant human granulocyte colony-stimulating factor: effects on normal and leukaemic myeloid cells. Science 232, 61-65.
2. Demetri, G. D., Griffin, J. D. (1991) Granulocyte colony-stimulating factor and its receptor. Blood 78, 2791-2808.
3. Gabrilove, J. L. (1992) Clinical applications of granulocyte colony stimulating factor (G-CSF). Growth Factors 6, 187-191.
4. Chao, N. J., Schriber, J. R., Grimes, K., Long, G. D., Negrin, R. S., Raimondi, C. M., Homing, S. J., Brown, S. L., Miller, L., Blume, K. G. (1993) Granulocyte colony-stimulating factor "mobilized" peripheral blood progenitor cells accelerate granulocyte and platelet recovery after high dose chemotherapy. Blood 81, 2031-2035.
5. Cheers, C., Haigh, A. M., Kelso, A., Metcalf, D., Stanley, E. R., Young, A. M. (1988) Production of colony-stimulating factors (CSFs) during infection: separate determinations of macrophage-, granulocyte-, granulocyte-macrophage-, and multi-CSFs. Infect. Immun. 56, 247-251.
6. Nomura, H., Imazeki, I., Oheda, M., Kubuta, N., Tamura, M., Ono, M., Ueyama, Y., Asano, S. (1986) Purification and characterization of human granulocyte-colony stimulating factor (G-CSF). EMBO J. 5, 871-876.
7. Hoglund, M. (1998) Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF)-what is the difference? Med. Oncol. 15, 229-233.
8. Arakawa, T., Prestrelski, S. J., Narhi, L. O., Boone, T. C., Kenney, W. C. (1993) Cysteine 17 of recombinant human granulocyte colony stimulating factor is partially solvent exposed. J. Protein Chem. 12, 525-531.
9. Nagata, S., Tsuchiya, M., Asano, S., Kaziro, Y., Yamazaki, T., Yamamoto, O., Hirata, Y., Kubota, N., Oheda, M., Nomura, H. (1986) Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor. Nature 319, 415-418.
10. Oh-eda, M., Hasegawa, M., Hattori, K., Kuboniwa, H., Kojima, T., Orita, T., Tomonou, K., Yamazaki, T., Ochi, N. (1990) O-linked sugar chain of human colony stimulating factor protects it against polymerization and determination allowing it to retain its biological activity. J. Biol. Chem. 265, 11432-11435.
11. Ono, M., Oh-eda, M., Kamachi, S., Kata, M., Endo, Y., Ochi, N. (1992) Structure of G-CSF: significance of the sugar chain. J. Nutr. Sci. Vitaminol. (Tokyo) Spec. No., 337-340.
12. Mire-Sluis, A. R., Abernethy, H. A., Dolman, C., Thorpe, R. (1999) The effects of environmental and post translational modification on the biological activity of granulocyte colony-stimulating factor. Pharm. Pharmacol. Commun. 5, 45-49.
13. El Ouriaghli, F., Fujiwara, H., Melonhurst, J. J., Sconocchia, G., Hensel, N., Barrett, A. J. (2003) Neutrophil elastase enzymatically antagonizes the in vitro activity of G-CSF: implications for the regulation of granulopoiesis. Blood 101, 1752-1758.
14. Weinstein, Y., Ihle, J. N., Lavu, S., Reddy, E. P. (1986) Truncation of the c-myb gene by a retroviral integration in an interleukin-3-dependent myeloid leukemia cell line. Proc. Natl. Acad. Sci. USA 83, 5010-5014.
15. Blum, H., Beier, H., Gross, H. J. (1987) Improved silver staining of plant proteins, RNA and DNA in polyacrylamide gels. Electrophoresis 8, 93-99.
16. Wang, C., Eufemi, M., Turano, C., Giartosio, A. (1996) Influence of the carbohydrate moiety on the stability of glycoproteins. Biochemistry 35, 7299-7307.
17. Baudys, M., Uchio, T., Mix, D., Wilson, D., Wan Kim, S. (1995) Physical stability of insulin by glycosylation. J. Pharm. Sci. 84, 28-33.
18. Van Berkel, P. H. C., Geerts, M. E. J., van Veen, H. A., Kooiman, P. M., Pieper, F. R. (1995) Glycosylated and unglycosylated human lactoferrins both bind iron and show identical affinities towards human lysozyme and bacterial lipopolysaccharide, but differ in their susceptibilities towards proteolysis. Biochem. J. 312, 107-114.
19. Ehlers, M. R. W., Riordan, J. F. (1991) Membrane proteins with soluble counterparts: role of proteolysis in the release of transmembrane proteins. Biochemistry 30, 10065-10075.
20. Bazil, V. (1995) Physiological enzymic cleavage of leukocyte membrane molecules. Immunol. Today 16, 135-140.
21. Scuderi, P., Nez, P. A., Duerr, M. L., Wong, B. J., Valdez, C. M. (1991) Cathepsin G and leukocyte elastase inactivate human tumor necrosis factor and lymphotoxin. Cell. Immunol. 135, 299-313.
22. Van Kessel, K. P. M., van Strijp, J. A., Verhoef, J. (1991) Inactivation of human tumor necrosis factor-α by proteolytic enzymes released from stimulated human neutrophils. J. Immunol. 147, 3862-3893.
23. Padrines, M., Wolf, M., Walz, A., Baggiolini, M. (1994) Interleukin-8 processing by neutrophil elastase, cathepsin G and proteinase-3. FEBS Lett. 352, 231-235.
24. Leavell, K. J., Peterson, M. W., Gross, T. J. (1997) Human neutrophil elastase abolishes interleukin-8 chemotactic activity. J. Leukoc. Biol. 61, 361-366.
25. Ariel, A., Yavin, E. J., Hershoviz, R., Avron, A., Franitza, S., Hardan, I., Cahalon, L., Fridkin, M., Lider, O. (1998) IL-2 induces T cell adherence to extra-cellular matrix: inhibition of adherence and migration by IL-2 peptides generated by leukocyte elastase. J. Immunol. 161, 2465-2472.
26. Laouar, A., Villers, C., Sanceau, J., Maison, C., Colomb, M., Wietzerbin, J., Bauvois, B. (1993) Inactivation of IL-6 in vitro by monoblastic U937 cell plasma membranes involves both protease and peptidyl-transferase activities. Eur. J. Biochem. 215, 825-831.
27. Bank, U., Kupper, B., Reinhold, D., Hoffman, T., Ansorge, S. (1999) Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation. FEBS Lett. 461, 235-240.
28. Sareneva, T., Pirhonen, J., Cantell, K., Julkunen, I. (1995) N-glycosylation of human interferon-γ: glycans at Asn-25 are critical for protease resistance. Biochem. J. 308, 9-14.
29. Gervais, V., Zerial, A., Oschkinat, H. (1997) NMR investigations of the role of the sugar moiety in glycosylated recombinant human granulocyte-colony stimulating factor. Eur. J. Biochem. 247, 386-395.
30. Bank U and Ansorge S. (2001) More than destructive: neutrophil-derived serine proteases in cytokine bioactivity control. J. Leukoc. Biol. 69, 197-206.
31. Robache-Gallea, S., Morande, V., Bruneau, J. M., Schoot, B., Tagat, E., Realo, E., Chouaib, S., Roman-Roman, S. (1995) In vitro processing of human tumour necrosis factor-α. J. Biol. Chem. 270, 23688-23692.
32. Hazuda, D. J., Strickler, J., Kueppers, F., Simon, P. L., Young, P. R. (1990) Processing of IL-1 β precursor and inflammatory disease. J. Biol. Chem. 265, 6318-6322.
33. Mizutani, M., Schechter, N., Lazuras, G., Black, R. A., Kupper, T. S. (1991) Rapid and specific conversion of precursor interleukin 1 β (IL-1 β) to an active species by human mast cell chymase. J. Exp. Med. 174, 821-825.
34. Mueller, S. G., Paterson, A. J., Kudlow, J. E. (1990) Transforming growth factor α in arterioles: cell surface processing of 1st precursor by elastases. Mol. Cell. Biol. 10, 4596-4602.
35. Wright, D. E., Cheshier, S. H., Wagers, A. J., Randall, T. D., Christensen, J. L., Weissman, I. L. (2001) Cyclophosphaamide/granulocyte colony-stimulating factor causes selective moblization of bone marrow stem cells into the blood after M phase of the cell cycle. Blood 97, 2278-2285.
36. Levesque, J. P., Hendy, J., Takamatsu, Y., Williams, B., Winkler, I. G., Simmons, P. J. (2002) Mobilization by either cyclophosphamide or granulocyte colony-stimulating factor transforms the bone marrow into a highly proteolytic environment. Exp. Hematol. 30, 440-449.
37. Levesque, J. P., Takamatsu, Y., Nilsson, S. K., Haylock, D. N., Simmons, P. J. (2001) Vascular cell adhesion molecule 1 (CD106) is cleaved by neutrophil proteases in the bone marrow following hematopoietic cell mobilization by granulocyte colony-stimulating factor. Blood 98, 1289-1297.
38. Levesque, J. P., Hendy, J., Winkler, I. G., Takamatsu, Y., Simmons, P. J. (2003) Granulocyte colony stimulating factor induces the release in the bone marrow of proteases that cleave c-KIT receptor (CD117) from the surface of hematopoietic progenitor cells. Exp Hematol. 31, 109-117.
39. Lapidot, T., Petit, I. (2002) Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines and stromal cells. Exp. Hematol. 30, 973-981.
40. Nissen, C. (1994) Glycosylation of recombinant human granulocyte stimulating factor: implications for stability and potency. Eur. J. Cancer 30A (Suppl. 3), S12-S14.
41. Nissen, C., Dalle Carbonare, V., Moser, Y. (1994) In vitro comparison of the biological potency of glycosylated versus non-glycosylated rG-CSF. Drug Investig. 7, 346-352.
42. Navia, M. A., McKeever, B. M., Springer, J. P., Lin, T. Y., Williams, H. R., Fluder, E. M., Dorn, C. P., Hoogsteen, K. (1989) Structure of human neutrophil elastase in complex with a peptide chloromethyl ketone inhibitor at 1.84-A resolution. Proc. Natl. Acad. Sci. USA 86, 7-11.